NKGen Biotech (NKGN) Financial Statements
NKGen Biotech Financial Overview
NKGen Biotech's market cap is currently $1.44M. The company's EPS TTM is $-1.03; its P/E ratio is -0.01; NKGen Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 77.00K | $ 426.00K |
| Gross Profit | $ 0.00 | $ 0.00 | $ 59.00K | $ 396.00K |
| Operating Income | $ -26.97M | $ -29.75M | $ -24.35M | $ -21.86M |
| EBITDA | $ -40.19M | $ -81.00M | $ -23.23M | $ -20.70M |
| Net Income | $ -44.29M | $ -82.95M | $ -26.75M | $ -23.27M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 0.00 | $ 26.00K | $ 117.00K | $ 351.00K |
| Total Assets | $ 24.00K | $ 16.48M | $ 16.33M | $ 18.07M |
| Total Debt | $ 0.00 | $ 19.92M | $ 12.03M | $ 51.97M |
| Net Debt | $ 0.00 | $ 19.89M | $ 11.92M | $ 51.62M |
| Total Liabilities | $ 0.00 | $ 75.17M | $ 14.77M | $ 56.12M |
| Stockholders' Equity | $ 0.00 | $ -58.69M | $ 1.56M | $ -38.05M |
| Cash Flow | ||||
| Free Cash Flow | $ -20.88M | $ -22.00M | $ -22.72M | $ -20.01M |
| Operating Cash Flow | $ -20.88M | $ -21.95M | $ -22.56M | $ -19.55M |
| Investing Cash Flow | $ -13.00K | $ -48.00K | $ -163.00K | $ -459.00K |
| Financing Cash Flow | $ 20.85M | $ 22.16M | $ 22.49M | $ 20.16M |
Currency in USD